De-Risking Drug Development | Episode 1: How To Drive Value In Pre-Clinical Development

By Balazs Felcsuti, Partner at Health Advances; Kristina Reeder, Director, Patient Engagement; Jamie L. Kistler, Ph.D., Executive Director, Customer Strategy, Medical Communications; and Paul Bridges, Ph.D., Executive Vice President & Global Head, Consulting

"De-risking Drug Development" is a comprehensive podcast series spanning five episodes that delve into pivotal decisions shaping the drug development journey. This series aims to enhance revenue outcomes for novel therapies through strategic decision-making across various stages.

Episode one critically examines the pre-clinical phase, emphasizing its pivotal role in product success. We explore how biotech sponsors translate scientific breakthroughs into viable clinical applications, crucial for effective investor communication. Early strategic planning with key stakeholders is highlighted, stressing the significance of integrating patient perspectives from the outset to drive commercial viability.